Showing results (571-580 of 868) with videos related to
Sort By:
Pageof 87
Head & Neck|December 24, 2014
Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximabShrujal S Baxi, Caitriona O'Neill, Eric J Sherman, et al.Trials|October 22, 2009
Effectiveness of focused structural massage and relaxation massage for chronic low back pain: protocol for a randomized controlled trialDaniel C Cherkin, Karen J Sherman, Janet Kahn, et al.BMC Medical Research Methodology|October 29, 2009
Comparing recruitment strategies in a study of acupuncture for chronic back painKaren J Sherman, Rene J Hawkes, Laura Ichikawa, et al.BMC Complementary and Alternative Medicine|July 21, 2004
Complementary and alternative medical therapies for chronic low back pain: What treatments are patients willing to try?Karen J Sherman, Daniel C Cherkin, Maureen T Connelly, et al.Journal of the National Cancer Institute|January 6, 1993
History of circumcision, medical conditions, and sexual activity and risk of penile cancerC Maden, K J Sherman, A M Beckmann, et al.Journal of Orofacial Pain|March 10, 2010
The Research Diagnostic Criteria for Temporomandibular Disorders. IV: evaluation of psychometric properties of the Axis II measuresRichard Ohrbach, Judith A Turner, Jeffrey J Sherman, et al.The Canadian Journal of Cardiology|October 1, 1994
Trends in the prevalence of congenital heart disease: comprehensive observations over a 24-year period in a defined region of CanadaD L Roy, L McIntyre, D G Human, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentClarissa M Howe, Leah R Hanson, Marcel G Hungs, et al.Sexually Transmitted Diseases|July 1, 1990
Sexually transmitted diseases and tubal pregnancyK J Sherman, J R Daling, A Stergachis, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 15, 1995
The tolerability and pharmacokinetics of N-butyl-deoxynojirimycin in patients with advanced HIV disease (ACTG 100). The AIDS Clinical Trials Group (ACTG) of the National Institute of Allergy and Infectious DiseasesM Tierney, J Pottage, H Kessler, et al.Pageof 87